Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
MBBS, FCPS, MCPS
Internal Medicine Specialist
M.B.B.S, Diplomat of American Board (Infectious Disease), Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S, Diplomat of American Board (Infectious Disease), Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, M.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P. (UK)*
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Rheumatologist
MBBS, FCPS (Medicine), Fellowship in Rheumatology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
General Physician
M.B.B.S, MCPS (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures